UBS Group’s PACS Group PACS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.5M Buy
270,036
+52,243
+24% +$1.88M ﹤0.01% 3290
2026
Q1
$7M Buy
217,793
+72,232
+50% +$2.66M ﹤0.01% 3714
2025
Q4
$5.59M Sell
145,561
-175,803
-55% -$3.86M ﹤0.01% 3909
2025
Q3
$4.41M Buy
321,364
+233,919
+268% +$2.74M ﹤0.01% 4161
2025
Q2
$1.13M Buy
87,445
+5,854
+7% +$60.9K ﹤0.01% 5342
2025
Q1
$917K Buy
81,591
+45,800
+128% +$601K ﹤0.01% 5353
2024
Q4
$469K Buy
35,791
+9,522
+36% +$244K ﹤0.01% 5894
2024
Q3
$1.05M Buy
26,269
+18,791
+251% +$683K ﹤0.01% 4606
2024
Q2
$221K Buy
+7,478
New +$204K ﹤0.01% 5592

Other funds holding PACS

UBS Group's PACS Position: Q2 2026 in Review

UBS Group increased its PACS Group (PACS) stake by 24% in Q2 2026, buying an estimated $1.88M and bringing the position to 270,036 shares worth $11.5M. The position accounts for ﹤0.01% of the portfolio, ranked #3290.

UBS Group first reported a position in PACS in Q2 2024 and has held it in 9 quarters since. 239 funds tracked by Wall St. Rank hold PACS as of Q2 2026.

  • UBS Group held 270,036 shares of PACS Group worth $11.5M as of Q2 2026.
  • UBS Group bought 52,243 PACS Group shares in Q2 2026, an estimated $1.88M.
  • PACS Group made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3290 holding.
  • UBS Group first reported a position in PACS Group in Q2 2024 and has held it in 9 quarters since.
  • 239 funds tracked by Wall St. Rank held PACS Group as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.